首页> 外文期刊>Analytical and quantitative cytology and histology >Expression of AFP, P-sel, and MMP-9 in Cirrhosis with Portal Vein Thrombosis
【24h】

Expression of AFP, P-sel, and MMP-9 in Cirrhosis with Portal Vein Thrombosis

机译:AFP,P-SEL和MMP-9在肝硬化中的表达与门静脉血栓形成

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To discuss and analyze the expression and clinical significance of serum alpha-fetoprotein (AFP), P-selectin (P-sel), and matrix metalloproteinase–9 (MMP-9) in hepatic sclerosis combined with portal vein thrombosis (PVT). Study Design: In this retrospective study, 38 patients with hepatic sclerosis combined with PVT diagnosed from August 2010 to February 2018 were chosen as the observation group. During the same period, 120 hepatic sclerosis patients without PVT were chosen as the control group. The serum AFP, P-sel, and MMP-9 expression levels of both groups were detected. Mean- while, the expression levels of AFP, P-sel, and MMP-9 in liver tissue samples of the 2 groups were detected using the Elivision immunohistochemical method. The correlation and clinical significance of AFP, P-sel, and MMP-9 were evaluated. Results: In the observation group there were 9 cases with splenectomy (23.7%) and 13 with diabetes (34.2%). In the control group there were 3 cases with splenectomy (2.5%) and 14 with diabetes (11.7%). The comparison differences showed statistical significance (p<0.05). The levels of serum AFP, P-sel, and MMP-9 in the observation group were higher than those in the control group, and the difference was statistically significant (p<0.05). Among the 158 patients the best diagnostic thresholds for AFP, P-sel, and MMP-9 in the diagnosis of cirrhosis with PVT were 25.22 IU/mL, 292.22 ng/mL, and 372.43 ng/mL, respectively, and the AUC values were 0.779, 0.722, and 0.755, respectively. Multivariate logistic regression analysis showed that AFP (OR=2.244), P-sel (OR=3.179), and MMP-9 (OR=2.508) were the main risk factors for PVT (p < 0.05). The expression level of AFP was positively correlated with the expression of P-sel and MMP-9 in hepatic sclerosis patients with PVT. Conclusion: Serum AFP, P-sel, and MMP-9 present high expression in hepatic sclerosis combined with PVT, with high diagnosis sensitivity and specificity, and may have synergistic effect on the pathogenesis leading to PVT.
机译:目的:讨论和分析血清α-胎儿(AFP),P-SELETIN(P-SEL)和基质金属蛋白酶-9(MMP-9)与门静脉血栓形成(PVT)的表达及基质金属蛋白酶-9(MMP-9)的表达及临床意义。研究设计:在这项回顾性研究中,从2010年8月至2018年8月诊断为2010年8月诊断的PVT,38例肝硬化患者被选为观察组。在同一时期,选择120例没有PVT的肝脏硬化患者作为对照组。检测两个组的血清AFP,P-SEL和MMP-9表达水平。虽然,使用Eliviot免疫组织化学方法检测2组肝组织样品中AFP,P-SEL和MMP-9的表达水平。评估AFP,P-SEL和MMP-9的相关性和临床意义。结果:在观察组中,脾切除术(23.7%)和13例糖尿病(34.2%)。在对照组中,3例脾切除术(2.5%)和14例,糖尿病(11.7%)。比较差异显示出统计学意义(P <0.05)。观察组中的血清AFP,P-SEL和MMP-9的水平高于对照组中的水平,差异有统计学意义(P <0.05)。在158名患者中,AFP,P-SEL和MMP-9在肝硬化诊断中,PVT的诊断阈值分别分别为25.22 IU / mL,292.22ng / mL和372.43ng / mL,并且AUC值0.779,0.722和0.755分别。多变量逻辑回归分析显示AFP(或= 2.244),P-SEL(或3.179)和MMP-9(或= 2.508)是PVT的主要风险因素(P <0.05)。 AFP的表达水平与肝硬化患者的P-SEL和MMP-9表达呈正相关。结论:血清AFP,P-SEL和MMP-9在肝硬化中的高表达结合PVT,具有高诊断敏感性和特异性,可能对导致PVT的发病机制具有协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号